Stat3-dependent induction of p19(INK4D) by IL-10 contributes to inhibition of macrophage proliferation

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4607-4615

  O'Farrell, Anne Marie ^a,c   Parry, David A ^a   Zindy, Frederique ^b   Roussel, Martine F ^b   Lees, Emma ^a   Moore, Kevin W ^a   Mui, Alice L F ^a,d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; INTERLEUKIN 10; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; MACROPHAGE; MITOSIS INHIBITION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0034193958     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4607     Document Type: Article

References (48)

1. Borish, L. 1998. IL-10: evolving concepts. J. Allergy Clin. Immunol. 101:293.
2. de Waal Malefyt, R., and K. W. Moore. 1998. Interleukin-10. In The Cytokine Handbook, 3rd Ed. Academic Press, New York, p. 332.
3. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
4. Koppelman, B., J. J. Neefjes, J. E. de Vries, and R. de Waal Malefyt. 1997. Interleukin-10 down-regulates MHC class II αβ peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7:861.
5. Song, S., H. Ling-Hu, K. A. Roebuck, M. F. Rabbi, R. P. Donnelly, and A. Finnegan. 1997. Interleukin-10 inhibits interferon-γ-induced intercellular adhesion molecule-1 gene transcription in human monocytes. Blood 89:4461.
6. O'Farrell, A. M., Y. Liu, K. W. Moore, and A. L. Mui. 1998. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J. 17:1006.
7. Ho, A. S., Y. Liu, T. A. Khan, D. H. Hsu, J. F. Bazan, and K. W. Moore. 1993. A receptor for interleukin 10 is related to interferon receptors. Proc. Natl. Acad. Sci. USA 90:11267.
8. Liu, Y., S. H. Wei, A. S. Ho, R. de Waal Malefyt, and K. W. Moore. 1994. Expression cloning and characterization of a human IL-10 receptor. J. Immunol. 152:1821.
9. Kotenko, S. V., C. D. Krause, L. S. Izotova, B. P. Pollack, W. Wu, and S. Pestka. 1997. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J. 16:5894.
10. Spencer, S. D., F. Di Marco, J. Hooley, S. Pitts-Meek, M. Bauer, A. M. Ryan, B. Sordat, V. C. Gibbs, and M. Aguet. 1998. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J. Exp. Med. 187:571.
11. Ho, A. S., S. H. Wei, A. L. Mui, A. Miyajima, and K. W. Moore. 1995. Functional regions of the mouse interleukin-10 reeeptor cytoplasmic domain. Mol. Cell. Biol. 15:5043.
12. Weber-Nordt, R. M., J. K. Riley, A. C. Greenlund, K. W. Moore, J. E. Darnell, and R. D. Schreiber. 1996. Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J. Biol. Chem. 271:27954.
13. Finbloom, D. S., and K. D. Winestock. 1995. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1α and STAT3 complexes in human T cells and monocytes. J. Immunol. 155:1079.
14. Lai, C. F., J. Ripperger, K. K. Morella, J. Jurlander, T. S. Hawley, W. E. Carson, T. Kordula, M. A. Caligiuri, R. G. Hawley, G. H. Fey, and H. Baumann. 1996. Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements. J. Biol. Chem. 271:13968.
15. Wehinger, J., F. Gouilleux, B. Groner, J. Finke, R. Mertelsmann, and R. M. Weber-Nordt. 1996. IL-10 induces DNA binding activity of ihree STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett. 394:365.
16. Takeda, K., B. E. Clausen, T. Kaisho, T. Tsujimura, N. Terada, I. Forster, and S. Akira. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39.
17. Riley, J. K., K. Takeda, S. Akira, and R. D. Schreiber. 1999. Interleukin-10 receptor signaling through the JAK-STAT pathway: requirement for two distinct receptor-derived signals for anti-inflammatory action.J. Biol. Chem. 274:16513.
18. Chellappan, S. P., A. Giordano, and P. B. Fisher. 1998. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Curr. Top. Microbiol. Immunol. 227:57.
19. Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704.
20. Guan, K. L., C. W. Jenkins, Y. Li, M. A. Nichols, X. Wu, C. L. O'Keefe, A. G. Matera, and Y. Xiong. 1994. Growth suppression by p18, a p16INK4/ MTS1-and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8:2939.
21. Hirai, H., M. F. Roussel, J. Y. Kato, R. A. Ashmun, and C. J. Sherr. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15:2672.
22. Brotherton, D. H., V. Dhanaraj, S. Wick, L. Brizuela, P. J. Domaille, E. Volyanik, X. Xu, E. Parisini, B. O. Smith, S. J. Archer, et al. 1998. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4D. Nature 395:244.
23. 1 phase progression. Genes Dev. 13:1501.
24. Hannon, G. J., and D. Beach. 1994. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257.
25. Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9:1831.
26. Sangfelt, O., S. Erickson, S. Einhorn, and D. Grander. 1997. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-α in hematopoietic cell lines. Oncogene 14:415.
27. Arora, T., and D. F. Jelinek. 1998. Differential myeloma cell responsiveness to interferon-alpha correlates with differential induction of p19 (INK4D) and cyclin D2 expression. J. Biol. Chem. 273:11799.
28. Chin, Y. E., M. Kitagawa, W. C. Su, Z. H. You, Y. Iwamoto, and X. Y. Fu. 1996. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/ CIP1 mediated by STAT1. Science 272:719.
29. Morse, L., D. Chen, D. Franklin, Y. Xiong, and S. Chen-Kiang. 1997. Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6. Immunity 6:47.
30. Taga, K., and G. Tosato. 1992. IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148:1143.
31. + T cell clones and resting T cells: specific inhibition of IL-2 production and proliferation. J. Immunol. 150:4754.
32. Bruserud, O., B. Tore Gjertsen, O. Terje Brustugun, C. F. Bassoe, I. Nesthus, P. Espen Akselsen, H. J. Buhring, and G. Pawelec. 1995. Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia. Leukemia 9:1910.
33. Geissler, K., L. Ohler, M. Fodinger, I. Virgolini, M. Leimer, E. Kabrna, M. Kollars, S. Skoupy, B. Bohle, M. Rogy, and K. Lechner. 1996. Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells. J. Exp. Med. 184:1377.
34. Oehler, L., M. Foedinger, M. Koeller, M. Kollars, E. Reiter, B. Bohle, S. Skoupy, G. Fritsch, K. Lechner, and K. Geissler. 1997. Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release. Blood 89:1147.
35. Schibler, K. R., Y. Li, R. K. Ohls, N. C. Nye, M. C. Durham, W. White, K. W. Liechty, T. Le, and R. D. Christensen. 1994. Possible mechanisms accounting for the growth factor independence of hematopoietic progenitors from umbilical cord blood. Blood 84:3679.
36. Zindy, F., Cunningham J. J., C. J. Sherr, S. Jogal, R. J. Smeyne, and M. F. Roussel. 1999. Postnatal neuronal proliferation in mice lacking ink4d and kip1 inhibitors of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 963: 13462.
37. O'Farrell, A. M., M. Ichihara, A. L. Mui, and A. Miyajima. 1996. Signaling pathways activated in a unique mast cell line where interleukin-3 supports survival and stem cell factor is required for a proliferative response. Blood 87:3655.
38. Zhang, Z., and G. M. Fuller. 1997. The competitive binding of STAT3 and NF-KB on an overlapping DNA binding site. Biochem. Biophys. Res. Commun. 237:90.
39. Ali, J. A., A. P. Jackson, A. J. Howells, and A. Maxwell. 1993. The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs. Biochemistry 32:2717.
40. Farrar, M. A., Alberol-Ila, and R. M. Perlmutter. 1996. Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization. Nature 383:178.
41. 1 phase arrest through up-regulated expression of CDK inhibitors, p19INK4D and p21Cip1 in mouse macrophages. Oncogene 16:2075.
42. Adachi, M., M. F. Roussel, K. Havenith, and C. J. Sherr. 1997. Features of macrophage differentiation induced by p19INK4D, a specific inhibitor of cyclin D-dependent kinases. Blood 90:126.
43. Narimatsu, M., K. Nakajima, M. Ichiba, and T. Hirano. 1997. Association of Stat3-dependent transcriptional activation of p19INK4D with IL-6-induced growth arrest. Biochem. Biophys. Res. Commun. 238:764.
44. Ichiba, M., K. Nakajima, Y. Yamanaka, N. Kiuchi, and T. Hirano. 1998. Autoregulation of the Stat3 gene through cooperation with a cAMP-responsive element-binding protein. J. Biol. Chem. 273:6132.
45. Richards, C. D., C. Kerr, M. Tanaka, T. Hara, A. Miyajima, D. Pennica, F. Botelho, and C. M. Langdon. 1997. Regulation of tissue inhibitor of metalloproteinase-1 in fibroblasts and acute phase proteins in hepatocytes in vitro by mouse oncostatin M, cardiotrophin-1, and IL-6. J. Immunol. 159:2431.
46. Kojima, H., K. Nakajima, and T. Hirano. 1996. IL-6-inducible complexes on an IL-6 response element of the junB promoter contain Stat3 and 36 kDa CRE-like site binding protein(s). Oncogene 12:547.
47. Parry, D. A., D. Mahony, K. Wills, and E. Lees. 1999. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol. Cell. Biol. 19: 1775.
48. INK4a inhibits both CDK4-and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol. Cell. Biol. 19:1981.